Bromelain Supplement for Diabetic Foot Ulcers

This clinical trial focuses on exploring whether a supplement containing enteric-coated bromelain, known as Anaheal 1200 GDU, can help in healing wounds, reducing pain, and decreasing inflammation in individuals over 18 years old who have diabetic foot ulcers. Diabetic foot ulcers are a common complication for people with diabetes, often leading to severe consequences if not managed effectively. By comparing the effects of bromelain to a placebo, this study aims to find better treatment options that could improve healing and comfort for those affected by this condition. Participants in the study will be divided into two groups. One group will receive standard wound care treatment along with the bromelain supplement, while the other group will receive the same standard treatment with a placebo. Researchers will assess the size of the wound, the level of pain, and inflammation markers such as ESR and CRP at the start of the study and every two weeks. This will help determine the effectiveness of the bromelain supplement in promoting healing and reducing symptoms. All participants will be informed about the study procedures through a detailed consent form before joining.